Molecular Formula | C17H19FN2O2 |
Molar Mass | 302.34 |
Density | 1.189 |
Boling Point | 479.0±40.0 °C(Predicted) |
pKa | 16.03±0.50(Predicted) |
Storage Condition | 2-8°C(protect from light) |
In vivo study | Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model: 81 adult male Sprague–Dawley male rats (260–460 g) Dosage: 80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative) Administration: Oral gavage; twice daily; until postoperative day 42 Result: Suppressed neuropathic pain. |